depemokimab

Trials studying depemokimab

• phase3Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trialrecruitingn=109
• phase3A Study of Depemokimab in Participants of 6 to 11 Years of Agerecruitingn=34
• phase4Efficacy and Safety of Depemokimab Monotherapy Without Concomitant Use of Intranasal Corticosteroids (INCS) in Japanese Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)not yet recruitingn=28
• phase3Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)active not recruitingn=163
• phase3Depemokimab Asthma Imaging and Bronchoscopy Sub-Studyrecruitingn=150
• phase3Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)recruitingn=960
• phase3A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthmanot yet recruitingn=456
• phase3An Open-Label Extension Study of GSK3511294 (Depemokimab) in Participants Who Were Previously Enrolled in 206713 (NCT04719832) or 213744 (NCT04718103)completedn=641